PE20090316A1 - Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias - Google Patents

Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias

Info

Publication number
PE20090316A1
PE20090316A1 PE2008000899A PE2008000899A PE20090316A1 PE 20090316 A1 PE20090316 A1 PE 20090316A1 PE 2008000899 A PE2008000899 A PE 2008000899A PE 2008000899 A PE2008000899 A PE 2008000899A PE 20090316 A1 PE20090316 A1 PE 20090316A1
Authority
PE
Peru
Prior art keywords
agent
treatment
pharmaceutical composition
combination
composition including
Prior art date
Application number
PE2008000899A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Murillo Josefina Santos
Ochoa Victor Guillermo Alvarez
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40075300&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090316(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of PE20090316A1 publication Critical patent/PE20090316A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE: A) UN AGENTE ANTIMICROBIANO TAL COMO CIPROFLOXACINO QUE SE ENCUENTRA EN UNA CANTIDAD DE 250MG A 1G EN LA COMPOSICION; Y B) UN AGENTE ANTIOXIDANTE TAL COMO ACIDO ASCORBICO (VITAMINA C) QUE SE ENCUENTRA EN UNA CANTIDAD DE 50MG A 200MG EN LA COMPOSICION. DICHA COMPOSICION ES UNA COMBINACION SINERGICA UTIL EN EL TRATAMIENTO DE INFECCION URINARIA Y FORMULADA EN UNA SOLA UNIDAD DE DOSIFICACION PARA SU ADMINISTRACION POR VIA ORAL EN FORMA DE CAPSULAS O TABLETAS
PE2008000899A 2007-05-28 2008-05-27 Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias PE20090316A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007006334A MX2007006334A (es) 2007-05-28 2007-05-28 Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias.

Publications (1)

Publication Number Publication Date
PE20090316A1 true PE20090316A1 (es) 2009-04-04

Family

ID=40075300

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000899A PE20090316A1 (es) 2007-05-28 2008-05-27 Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias

Country Status (13)

Country Link
EP (1) EP2149374B1 (es)
AR (1) AR067320A1 (es)
BR (1) BRPI0811627A2 (es)
CL (1) CL2008001536A1 (es)
CO (1) CO6241114A2 (es)
CY (1) CY1113544T1 (es)
EC (1) ECSP099733A (es)
ES (1) ES2394736T3 (es)
GT (1) GT200900295A (es)
MX (1) MX2007006334A (es)
PE (1) PE20090316A1 (es)
PL (1) PL2149374T3 (es)
WO (1) WO2008147167A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180360855A1 (en) * 2015-12-25 2018-12-20 Yusuf Toktamis ÖGÜN The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
RU2637650C2 (ru) * 2016-03-29 2017-12-05 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Композиция для профилактики заболеваний мочевыводящих путей

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020169112A1 (en) * 2001-05-08 2002-11-14 Luc Montagnier Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US8003616B2 (en) * 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US8153166B2 (en) * 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
US20080114054A1 (en) * 2006-11-14 2008-05-15 Rath Microbes Compositions and methods for reducing antimicrobial resistance of microbes

Also Published As

Publication number Publication date
WO2008147167A1 (es) 2008-12-04
EP2149374A1 (en) 2010-02-03
ECSP099733A (es) 2009-12-28
CO6241114A2 (es) 2011-01-20
MX2007006334A (es) 2009-02-18
EP2149374B1 (en) 2012-10-10
PL2149374T3 (pl) 2013-05-31
ES2394736T3 (es) 2013-02-05
AR067320A1 (es) 2009-10-07
CL2008001536A1 (es) 2009-04-03
CY1113544T1 (el) 2016-06-22
BRPI0811627A2 (pt) 2014-11-11
EP2149374A4 (en) 2010-12-08
GT200900295A (es) 2011-11-15

Similar Documents

Publication Publication Date Title
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
MX345238B (es) (aralquilamino y heteroarilalquilamino alfa-substituidos)pirimidin ilo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas.
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
UY31780A (es) Fenoxibenzamidas sustituidas
BR112012013252A2 (pt) composição farmacêutica tópica, preservativo, composto, e, uso do mesmo
BR112014020271A8 (pt) Composição farmacêutica e métodos para diminuir a frequência de micção em paciente
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
UY33061A (es) Composiciones para comprimidos desintegrables oralmente de ondansetrón para prevenir náuseas y vómitos
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
CO6640318A2 (es) Formas de dosificación oral de bendamustina
AR095032A1 (es) Formulaciones de compuestos orgánicos, composición farmacéutica sólida comprimida por rodillo
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
PE20090316A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias
CR10407A (es) Formulacion de medicamento liquida.
ECSP11010998A (es) Formulación galénica que comprende alisquireno y proceso para su preparación mediante granulación de extrusión fundida
BRPI1010987B8 (pt) composições de dosagem sólida de liberação controlada contendo ibuprofeno
ECSP13012369A (es) Agentes terapéuticos 976
PE20090725A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartrosis y enfermedades relacionadas
UY31212A1 (es) Composición farmacéutica que comprende la combinación de un agente derivado benzisoxazolico y un agente benzodiazepinico

Legal Events

Date Code Title Description
FG Grant, registration
AE Restoration of lapsed or forfeited application
FG Grant, registration
FD Application declared void or lapsed